Neutral displacement needles market set to reach $430 million by 2030

The global neutral displacement needles market is projected to rise from $280 million in 2025 to $300 million in 2026, according to a new Business Research Company report. Growth is being driven by infection-control priorities, higher IV therapy use and demand for safer vascular access devices.

Why it matters: - Neutral displacement needles are gaining traction as hospitals and infusion providers look for ways to reduce catheter-related bloodstream infections and other healthcare-associated infections. - The market outlook points to sustained demand for safer vascular access devices as healthcare systems expand intravenous therapy, home infusion and closed-system drug delivery. - The report suggests the category could become a larger part of infection-control spending as providers prioritize patient safety and fluid stability.

What happened: - The Business Research Company published its Neutral Displacement Needles Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market was valued at $280 million in 2025 and is expected to reach $300 million in 2026. - The report projects the market will climb to $430 million by 2030. - North America was the largest market in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - Neutral displacement needles are designed to balance fluid movement when devices are connected and disconnected, helping reduce unwanted pressure changes in closed systems. - The devices help limit reflux and support stable fluid control during medical procedures. - The report links growth to wider adoption of intravenous therapy, increased focus on reducing healthcare-associated infections and demand for needle-free access systems. - Additional drivers include hospital and infusion care expansion, rising awareness of patient safety protocols and more investment in next-generation medical access devices. - The report also cites growing interest in closed-system drug delivery devices, advanced infection-control technologies and effective fluid management solutions. - Home infusion therapy and biocompatible material development are also shaping the market. - The report lists broader adoption of closed-system neutral displacement devices, more demand for advanced fluid control in IV therapy and a preference for needle-free access to protect healthcare workers among key trends. - The report includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa as additional regions analyzed. - The Business Research Company added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics to its 2026 reports. - A free sample report is available here, and the full report is available here.

Between the lines: - The report’s infection-control emphasis suggests demand is being pulled not just by product replacement cycles, but by clinical pressure to reduce avoidable complications. - The cited infection data from the UK and US underscores why catheter safety remains a procurement priority in intensive care and other high-risk settings. - Rising healthcare spending can make it easier for facilities to adopt higher-cost devices that promise better compliance and lower downstream infection risk.

What's next: - The market is expected to continue growing through 2030 as healthcare systems expand access to safer infusion technologies. - Adoption should rise where providers are trying to reduce reflux, protect staff and strengthen infection-control protocols. - Regional growth will likely vary by healthcare infrastructure, spending levels and infection-prevention priorities.

The bottom line: - Neutral displacement needles are moving from a niche access product toward a broader infection-prevention tool in modern care settings.